Viewing Study NCT02891551

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2026-02-04 @ 2:30 AM
Study NCT ID: NCT02891551
Status: COMPLETED
Last Update Posted: 2019-07-24
First Post: 2015-10-20
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: An Observational Post Authorisation Study to Evaluate Safety and Efficacy in Patients Receiving Azacitidine in Daily Clinical Practice in the Netherlands
Sponsor: Celgene
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndromes View
None Leukemia, Myelomonocytic, Chronic View
None Leukemia, Myeloid, Acute View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Leukemia View
None Chronic View
None Acute View
None Observational View
None Non-interventional View
None OCEAN View
None Netherlands View
None azacitidine View